Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Kirkpatrick

Showing results (141-150 of 156) with videos related to

Pageof 16
Sort By:
Advances in Radiation Oncology|December 22, 2021
Outcomes in Patients With 4 to 10 Brain Metastases Treated With Dose-Adapted Single-Isocenter Multitarget Stereotactic Radiosurgery: A Prospective StudyGrace J Kim, Evan D Buckley, James E Herndon, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2017
Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)Paul W Sperduto, Wen Jiang, Paul D Brown, et al.
International Journal of Radiation Oncology, Biology, Physics|July 20, 2017
The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain MetastasesPaul W Sperduto, Wen Jiang, Paul D Brown, et al.
Practical Radiation Oncology|July 28, 2022
Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice GuidelineLia M Halasz, Albert Attia, Lisa Bradfield, et al.
Practical Radiation Oncology|June 27, 2025
Radiation Therapy for WHO Grade 4 Adult-Type Diffuse Glioma: An ASTRO Clinical Practice GuidelineDebra Nana Yeboa, Steve E Braunstein, Alvin Cabrera, et al.
JAMA Oncology|November 29, 2016
Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
International Journal of Radiation Oncology, Biology, Physics|September 7, 2016
The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain MetastasesPaul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
Neuro-Oncology|November 13, 2018
Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment toolPaul W Sperduto, Brian J Deegan, Jing Li, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2018
Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain MetastasesPaul W Sperduto, Brian J Deegan, Jing Li, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 20, 2019
Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress?Paul W Sperduto, Penny Fang, Jing Li, et al.
Pageof 16

Showing results (141-150 of 156) with videos related to

Sort By:
Pageof 16
Advances in Radiation Oncology|December 22, 2021
Outcomes in Patients With 4 to 10 Brain Metastases Treated With Dose-Adapted Single-Isocenter Multitarget Stereotactic Radiosurgery: A Prospective StudyGrace J Kim, Evan D Buckley, James E Herndon, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2017
Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)Paul W Sperduto, Wen Jiang, Paul D Brown, et al.
International Journal of Radiation Oncology, Biology, Physics|July 20, 2017
The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain MetastasesPaul W Sperduto, Wen Jiang, Paul D Brown, et al.
Practical Radiation Oncology|July 28, 2022
Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice GuidelineLia M Halasz, Albert Attia, Lisa Bradfield, et al.
Practical Radiation Oncology|June 27, 2025
Radiation Therapy for WHO Grade 4 Adult-Type Diffuse Glioma: An ASTRO Clinical Practice GuidelineDebra Nana Yeboa, Steve E Braunstein, Alvin Cabrera, et al.
JAMA Oncology|November 29, 2016
Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
International Journal of Radiation Oncology, Biology, Physics|September 7, 2016
The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain MetastasesPaul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
Neuro-Oncology|November 13, 2018
Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment toolPaul W Sperduto, Brian J Deegan, Jing Li, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2018
Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain MetastasesPaul W Sperduto, Brian J Deegan, Jing Li, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 20, 2019
Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress?Paul W Sperduto, Penny Fang, Jing Li, et al.
Pageof 16